As the Covid-19 epidemic continues, our wound center partners find themselves navigating an entirely new landscape. Randy Brooker, President of Center Operations, has managed wound care and hyperbaric medicine programs for over 15 years. He's also a certified hyperbaric technologist and former educator for various hyperbaric courses. Here, he answers common questions about Covid-19 and hyperbaric oxygen therapy (HBOT).
Back in 2011, our CEO Mike Comer wrote a blog post about whether to rent or buy a hyperbaric chamber for an outpatient wound care program, and that post continues to generate interest to this day. Since that time, our industry has experienced many changes, but the interest and need for hyperbaric oxygen therapy (HBOT) is still very much alive.
The OIG released the results of a MAC audit report on Hyperbaric Oxygen Therapy (HBOT) services. Based on the sample charts, they estimated there were over $39 million in HBOT overpayments for the sample year alone in this jurisdiction.